3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Uveal Melanoma
2
Melanoma
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of the Lung
1
Osteosarcoma
1
Neoplasm Metastasis
1
Interventions
glembatumumab vedotin
1
CR011-vcMMAE
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Squamous Cell Carcinoma of the Lung
×
CR011-vcMMAE
×
Clear all
NCT02713828
2019-07-16
PrE0504
PrECOG, LLC.
Phase 1/2
Terminated
13 enrolled
12 charts